Long-Term Clinical and Economic Analysis of the Endeavor Drug-Eluting Stent Versus the Driver Bare-Metal Stent: 4-Year Results From the ENDEAVOR II Trial (Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions)期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Long-Term Clinical and Economic Analysis of the Endeavor Drug-Eluting Stent Versus the Driver Bare-Metal Stent: 4-Year Results From the ENDEAVOR II Trial (Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions)

Authors:	Eric L. Eisenstein William Wijns Jean Fajadet Laura Mauri Rex Edwards Patricia A. Cowper David F. Kong Kevin J. Anstrom

Affiliation:	2. Cardiovascular Center, Aalst, Belgium;3. Clinique Pasteur, Toulouse, France;4. Harvard Clinical Research Institute, Brigham and Women''s Hospital, Harvard Medical School, Boston, Massachusetts

Abstract:

Keywords:
本文献已被 ScienceDirect 等数据库收录！